Results 11 to 20 of about 19,340 (214)

Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview [PDF]

Head & Neck, 2020
AbstractThe novel coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was declared a pandemic in March 2020. A plethora of respiratory sampling methods for SARS‐CoV‐2 viral detection has been used and in the current evolving situation, there is no international consensus on the recommended method ...
See, Anna, Toh, Song Tar
openaire   +2 more sources

Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature

Journal of Medical Case Reports, 2021
Introduction We report a case of Severe acute respiratory syndrome coronavirus-2 infection with acute pancreatitis as the only presenting symptom. To the best of our knowledge, there are few case reports of the same presentation.
Abdullah S. Eldaly, Ayman R. Fath, Sarah M. Mashaly, Muhammed Elhadi   +3 more
doaj   +1 more source

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

SAGE Open Medicine, 2022
Objectives: The severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019. A serological test is conducted to determine prior infection by severe acute respiratory syndrome coronavirus 2.
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, Shigeto Tohma   +6 more
doaj   +1 more source

SARS-CoV-2–related outcomes after surgical procedures on SARS-CoV-2–positive patients in a large, urban, safety net medical center

Surgery Open Science, 2021
Background: Beginning on March 16, 2020, nonurgent scheduled operations at a large, urban, safety net medical center were canceled. The purpose of this study was to determine complications associated with severe acute respiratory syndrome coronavirus 2 ...
Rachel E. Sargent, MD, Stephen F. Sener, MD, FACS, Rodolfo Amaya, MD, Elizabeth Vazquez, BA, Michael E. Bowdish, MD, MS, FACS, Brad Spellberg, MD   +5 more
doaj   +1 more source

Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes [PDF]

Frontiers in Endocrinology, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a worldwide epidemic. It spreads very fast and hits people of all ages, especially patients with underlying diseases such as diabetes. In this review, we focus on the influences of diabetes on the outcome of SARS-CoV-2 infection and the involved mechanisms including lung ...
Shiying Shao, Shiying Shao, Qin Yang, Ruping Pan, Xuefeng Yu, Xuefeng Yu, Yong Chen, Yong Chen   +7 more
openaire   +3 more sources

A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

Cureus, 2020
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus strain that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. It spread to several countries across continents and infected more than one million people within three months. While there is no consensus on the treatment of the disease
Baek, Woong Kee, Sohn, Soo-Yeon, Mahgoub, Ahmed, Hage, Robert   +3 more
openaire   +2 more sources

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

PLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara   +6 more
doaj   +3 more sources

Confirmed severe acute respiratory syndrome coronavirus 2 encephalitis in cerebrospinal fluid: a case report

Journal of Medical Case Reports, 2022
Background Patients with severe acute respiratory syndrome coronavirus 2 infection show various clinical manifestations, including neurological .
Triana Ayuningtyas, Ronald Irwanto Natadidjaja, Chyntia Octaviani, Felly Sahli, Hadianti Adlani   +4 more
doaj   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

Archives of Pathology & Laboratory Medicine, 2020
Context.— The novel coronavirus disease 2019 (COVID-19) pandemic is significantly changing methodologic approaches in all branches of the health system. From a forensic point of view, this event is partly changing the manner in which forensic pathologists and all those who work in autopsy services operate, but ...
Aquila, Isabella, Sacco, Matteo Antonio, Abenavoli, Ludovico, Malara, Natalia, Arena, Vincenzo, Grassi, Simone, Ausania, Francesco, Boccuto, Luigi, Ricci, Cristoforo, Gratteri, Santo, Oliva, Antonio, Ricci, Pietrantonio   +11 more
openaire   +4 more sources

M-targeted anti-SARS-CoV-2 inhibitor-based drugs

Journal of Chemical Research, 2023
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global health emergency. The main protease is an important drug target in coronaviruses.
Zhuxin She, Yinuo Yao, Conglong Wang, Yi Li, Xiaohui Xiong, Yuanyuan Liu   +5 more
doaj   +1 more source